Licensing Deal Pays Partner Only at Project Close
Operators structuring partner deals should note that equity compensation tied to financial close shifts development risk onto the partner.
Updated on Nov. 20, 2026 in Corporate Finance

Tersis Technologies signed an exclusive technology partnership, market development and equity participation agreement with Pingkas Capital, naming it exclusive market-development partner for SynGenic V3 in the Philippines. The deal is the definitive agreement contemplated by a May 2026 memorandum of understanding, and Pingkas can earn exclusivity country by country across Southeast, Northeast and South Asia as projects advance.
Why it matters
The structure ties Pingkas's exclusivity and compensation to project performance rather than upfront payment, paid in Tersis restricted common stock that is earned only at project financial close. For operators, it is a model of how a technology licensor can outsource market development and financing introductions while keeping ownership of its core technology.
The disclosed terms include no dollar values or equity percentages, with compensation payable in Tersis restricted common stock only at project financial close. The agreement covers three regional target markets (Southeast, Northeast and South Asia), with the Philippines as the first named country.
The players
Tersis Technologies, Inc.
Technology company that owns the SynGenic V3 technology and licenses it to partners for project development.
JL Equities Cap, LLC (Pingkas Capital)
Small capital firm serving as exclusive market-development and project-introduction partner for SynGenic V3.
The details
Under the agreement, Pingkas provides market and feasibility analysis, site and local government assessments, regulatory and permitting coordination, and introductions to feedstock suppliers, offtakers, landowners, lenders and local partners. Tersis supplies the SynGenic V3 technology along with engineering, training and operational support, and keeps ownership of the technology. Pingkas receives only a limited, non-exclusive license to use SynGenic V3 for evaluating, developing, marketing and financing projects under the agreement. Any Pingkas participation in an individual project company will be negotiated separately for that project.
Timeline
May 2026: Memorandum of understanding signed between the companies.
November 20, 2026: Definitive agreement announced and press release issued from Miami, Florida.
Market Landscape
The structure mirrors licensing arrangements where a technology owner retains ownership while a regional partner handles market access, with compensation deferred until projects reach financial close. Because payment is in restricted stock rather than cash, the arrangement shifts development risk toward the partner and aligns incentives with project completion.
Operators in licensing or project development should note that equity-based compensation tied to project financial close defers cost until results are realized. Companies evaluating similar partner arrangements should have qualified counsel review the equity and licensing terms before committing.
The takeaway
Watch whether the first Philippine site and feedstock agreement is signed, since that is the first concrete step toward any project under this structure. Operators considering contingent equity compensation for partners should have counsel assess how restricted stock vesting and project-closing conditions would be treated for their own business.
Further reading
For context on how companies structure deals like this one, see the Corporate Finance section.
Source note: This article includes information reported by Stratford Beacon Herald.

